The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury

Injuries to the central nervous system (CNS) usually lead to a potent and acute inflammatory response[1]. During this period, glia and immune cells respond to chemical cues associated with the debris of lysed neurons, disrupted axons, and a broken blood-brain-barrier by releasing a battery of cytoki...

Full description

Saved in:
Bibliographic Details
Main Authors: Damien D. Pearse, Francisco C. Pereira, Katina Chatzipanteli, Francisco W. Dalton Dietrich, Mary Bartlett Bunge
Format: Article
Language:English
Published: Wiley 2002-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1100/tsw.2002.63
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553266037129216
author Damien D. Pearse
Francisco C. Pereira
Katina Chatzipanteli
Francisco W. Dalton Dietrich
Mary Bartlett Bunge
author_facet Damien D. Pearse
Francisco C. Pereira
Katina Chatzipanteli
Francisco W. Dalton Dietrich
Mary Bartlett Bunge
author_sort Damien D. Pearse
collection DOAJ
description Injuries to the central nervous system (CNS) usually lead to a potent and acute inflammatory response[1]. During this period, glia and immune cells respond to chemical cues associated with the debris of lysed neurons, disrupted axons, and a broken blood-brain-barrier by releasing a battery of cytokines including tumor necrosis factor-α (TNF-α) and, interleukin-β (IL-1β) as well as reactive oxygen species such as nitric oxide (NO-)[2]. The secretion of these factors may be primarily responsible for secondary damage to surrounding uninjured tissue that potentiates the initial injury[3]. Antisense oligonucleotides (ASOs) are designed to hybridize to specific regions of specific mRNAs. Hybridization of the oligonucleotide to the mRNA then interferes with the normal processing of that mRNA at the ribosome or targets the RNA duplex for cleavage by the RNA digestive enzyme, ribonuclease H, resulting in greatly reduced expression of the coded protein. This effectively reduces the amount of corresponding translated protein product and experiments can be designed to examine the requirement of particular inflammatory agents in eliciting specific deleterious responses after injury, e.g., cell death.
format Article
id doaj-art-731849876c374c6485db88b727f25af2
institution Kabale University
issn 1537-744X
language English
publishDate 2002-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-731849876c374c6485db88b727f25af22025-02-03T05:54:28ZengWileyThe Scientific World Journal1537-744X2002-01-01213313510.1100/tsw.2002.63The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord InjuryDamien D. Pearse0Francisco C. Pereira1Katina Chatzipanteli2Francisco W. Dalton Dietrich3Mary Bartlett Bunge4The Miami Project to Cure Paralysis, Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, FL, USADepartment of Anatomy, University of Sao Paulo, BrazilThe Miami Project to Cure Paralysis, Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, FL, USAThe Miami Project to Cure Paralysis, Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, FL, USAThe Miami Project to Cure Paralysis, Department of Cell Biology and Anatomy, University of Miami School of Medicine, Miami, FL, USAInjuries to the central nervous system (CNS) usually lead to a potent and acute inflammatory response[1]. During this period, glia and immune cells respond to chemical cues associated with the debris of lysed neurons, disrupted axons, and a broken blood-brain-barrier by releasing a battery of cytokines including tumor necrosis factor-α (TNF-α) and, interleukin-β (IL-1β) as well as reactive oxygen species such as nitric oxide (NO-)[2]. The secretion of these factors may be primarily responsible for secondary damage to surrounding uninjured tissue that potentiates the initial injury[3]. Antisense oligonucleotides (ASOs) are designed to hybridize to specific regions of specific mRNAs. Hybridization of the oligonucleotide to the mRNA then interferes with the normal processing of that mRNA at the ribosome or targets the RNA duplex for cleavage by the RNA digestive enzyme, ribonuclease H, resulting in greatly reduced expression of the coded protein. This effectively reduces the amount of corresponding translated protein product and experiments can be designed to examine the requirement of particular inflammatory agents in eliciting specific deleterious responses after injury, e.g., cell death.http://dx.doi.org/10.1100/tsw.2002.63
spellingShingle Damien D. Pearse
Francisco C. Pereira
Katina Chatzipanteli
Francisco W. Dalton Dietrich
Mary Bartlett Bunge
The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
The Scientific World Journal
title The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
title_full The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
title_fullStr The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
title_full_unstemmed The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
title_short The Use of Antisense-Mediated Inhibition to Delineate The Role of Inflammatory Agents in The Pathophysiology of Spinal Cord Injury
title_sort use of antisense mediated inhibition to delineate the role of inflammatory agents in the pathophysiology of spinal cord injury
url http://dx.doi.org/10.1100/tsw.2002.63
work_keys_str_mv AT damiendpearse theuseofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT franciscocpereira theuseofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT katinachatzipanteli theuseofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT franciscowdaltondietrich theuseofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT marybartlettbunge theuseofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT damiendpearse useofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT franciscocpereira useofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT katinachatzipanteli useofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT franciscowdaltondietrich useofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury
AT marybartlettbunge useofantisensemediatedinhibitiontodelineatetheroleofinflammatoryagentsinthepathophysiologyofspinalcordinjury